Bausch & Lomb (STU:S2L) Price-to-Tangible-Book : (As of May. 05, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb Price-to-Tangible-Book?

As of today (2025-05-05), Bausch & Lomb's share price is €10.10. Bausch & Lomb's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was €-4.28. Hence, Bausch & Lomb's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Bausch & Lomb's Price-to-Tangible-Book or its related term are showing as below:

During the past 7 years, Bausch & Lomb's highest Price to Tangible Book Ratio was 22.68. The lowest was 11.58. And the median was 17.62.

STU:S2L's Price-to-Tangible-Book is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 2.6
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Bausch & Lomb's share price is €10.10. Bausch & Lomb's Book Value per Sharefor the quarter that ended in Mar. 2025 was €16.65. Hence, Bausch & Lomb's P/B Ratio of today is 0.61.

Bausch & Lomb Price-to-Tangible-Book Historical Data

The historical data trend for Bausch & Lomb's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Price-to-Tangible-Book Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Tangible-Book

Get a 7-Day Free Trial

11.09

Bausch & Lomb Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Tangible-Book	Get a 7-Day Free Trial														-	-	-	-	-

Competitive Comparison of Bausch & Lomb's Price-to-Tangible-Book

For the Medical Instruments & Supplies subindustry, Bausch & Lomb's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bausch & Lomb's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bausch & Lomb's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Bausch & Lomb's Price-to-Tangible-Book falls into.

Save Embed

;

Save Embed

;

Bausch & Lomb Price-to-Tangible-Book Calculation

Bausch & Lomb's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2025 )
	=	10.10	/	-4.275
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Bausch & Lomb Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (STU:S2L) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

BLCO:USA BLCO:Canada

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Bausch & Lomb Headlines

No Headlines